BackLilly(Eli) Overview
Lilly(Eli) & Co

Lilly(Eli) Target Price

See Lilly(Eli)'s analyst price targets ($1.3K) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1,220.51

Average Target Price

$1334.829.4% upside

22 analysts in the last 4 months

High: $1500 | Low: $1119

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-07UBS$1,37612.7% upsideOpen
2026-08-06Morgan Stanley$1,41916.3% upsideOpen
2026-08-06Wells FargoMohit Bansal$1,3309% upsideOpen
2026-08-06BMO CapitalEvan Seigerman$1,40014.7% upsideOpen
2026-08-06Cantor Fitzgerald$1,41015.5% upsideOpen
2026-07-14Bernstein$1,38513.5% upsideOpen
2026-07-13UBS$1,42516.8% upsideOpen
2026-07-13Guggenheim$1,2734.3% upsideOpen
2026-07-09UBS$1,37012.2% upsideOpen
2026-07-08Truist Financial$1,37012.2% upsideOpen
2026-07-08Morgan StanleyTerence Flynn$1,34710.4% upsideOpen
2026-07-08RBC Capital$1,50022.9% upsideOpen
2026-07-06Cantor Fitzgerald$1,35010.6% upsideOpen
2026-06-25Leerink PartnersDavid Risinger$1,2320.9% upsideOpen
2026-06-22Berenberg BankKerry Holford$1,1357% downsideOpen
2026-06-09Jefferies$1,35010.6% upsideOpen
2026-05-26HSBC$1,2512.5% upsideOpen
2026-05-26Leerink PartnersDavid Risinger$1,1198.3% downsideOpen
2026-05-21Wolfe Research$1,35010.6% upsideOpen
2026-05-05BarclaysEmily Field$1,40014.7% upsideOpen
2026-05-01Cantor FitzgeraldCarter Gould$1,2300.8% upsideOpen
2026-05-01Morgan Stanley$1,34410.1% upsideOpen
2026-04-10Morgan Stanley$1,3278.7% upsideOpen
2026-03-13JefferiesAkash Tewari$1,3006.5% upsideOpen
2026-03-06Deutsche BankJames Shin$1,2855.3% upsideOpen
2026-03-05Morgan StanleyTerence Flynn$1,3137.6% upsideOpen
2026-02-24RBC CapitalTrung Huynh$1,2502.4% upsideOpen
2026-02-19Barclays$1,35010.6% upsideOpen
2026-02-10Loop Capital MarketsIlya Zubkov$1,2001.7% downsideOpen
2026-02-05Truist Financial$1,2815% upsideOpen
2026-02-05Scotiabank$1,3006.5% upsideOpen
2026-02-05Goldman Sachs$1,2603.2% upsideOpen
2026-02-05BMO CapitalEvan Seigerman$1,3006.5% upsideOpen
2026-02-05Wells FargoMohit Bansal$1,2804.9% upsideOpen
2026-01-20Guggenheim$1,1614.9% downsideOpen
2026-01-06UBSMichael Yee$1,2502.4% upsideOpen
2026-01-05Leerink PartnersDavid Risinger$1,2341.1% upsideOpen
2025-12-16DaiwaNarumi Nakagiri$1,2300.8% upsideOpen
2025-12-15Goldman Sachs$1,1456.2% downsideOpen
2025-12-10HSBC$1,07012.3% downsideOpen
2025-12-04BMO Capital$1,2001.7% downsideOpen
2025-12-03Guggenheim$1,1634.7% downsideOpen
2025-12-02BMO CapitalEvan Seigerman$1,1009.9% downsideOpen
2025-12-01National BankTim Anderson$1,2865.4% upsideOpen
2025-11-24Morgan StanleyTerence Flynn$1,2905.7% upsideOpen
2025-11-24Bernstein$1,3006.5% upsideOpen
2025-11-19Truist FinancialSrikripa Devarakonda$1,1823.2% downsideOpen
2025-11-10Loop Capital MarketsIlya Zubkov$95022.2% downsideOpen
2025-10-31Cantor Fitzgerald$98519.3% downsideOpen
2025-10-09Cantor Fitzgerald$92524.2% downsideOpen

Lilly(Eli) (LLY) FAQ

Lilly(Eli) (LLY) currently reports a target price of $1.3K. Use the charts on this page to explore Lilly(Eli)'s target price history and peer comparisons.

Analysts' average 12-month price target for Lilly(Eli) is $1.3K, about 9.4% upside from the current share price of $1220.51. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $1.3K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lilly(Eli), and consider following LLY for alerts when major investors trade the stock.

Lilly(Eli) is classified in the Healthcare sector. On target price, it currently shows $1.3K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LLY with unrelated industries.